B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1300-1306

  Pogue, Sarah L ^a   Kurosaki, Tomohiro ^a,b   Bolen, Joseph ^a,c   Herbst, Ronald ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CROSS LINKING; LYMPHOMA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034254421     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1300     Document Type: Article

References (50)

1. Benschop, R. J., and J. C. Cambier. 1999. B cell development: signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 11:143.
2. Campbell, K. S. 1999. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 11:256.
3. Kurosaki, T. 1999. Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol. 17:555.
4. Cheng, A. M., B. Rowley, W. Pao, A. Hayday, J. B. Bolen, and T. Pawson. 1995. Syk tyrosinc kinase required for mouse viability and B-cell development. Nature 378:303.
5. Turner, M., P. J. Mee, P. S. Costello, O. Williams, A. A. Price, L. P. Duddy, M. T. Furlong, G. L. Geahlen, and V. L. J. Tybulewicz. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298.
6. Fu, C., C. W. Turck, T. Kurosaki, and A. C. Chan. 1998. BLNK: a central linker protein in B cell activation. Immunity 9:93.
7. Wienands, J., J. Schweikert, B. Wollscheid, H. Jumaa, P. J. Nielsen, and M. Reth. 1998. SLP-65: a new signaling component in B lymphocytes which requires expression of antigen receptor for phosphorylation. J. Exp. Med. 188:791.
8. Takata, M., Y. Homma, and T. Kurosaki. 1995. Requirement of phospholipase C-γ2 activation in surface immunoglobulin M-induced B cell apoptosis. J. Exp. Med. 184:907.
9. 2+ mobilization through distinct pathways. EMBO J. 13:1341.
10. Takata, M., and T. Kurosaki. 1996. A role for Burton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184: 31.
11. 2+ following B-cell receptor activation. EMBO J. 17:1973.
12. Nishizumi, H., K. Horikawa, R. I. Mlinaric, and T. Yamamoto. 1998. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 197:1343.
13. Smith, K., D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon. 1998. inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187:807.
14. Chan, V. W., C. A. Lowell, and A. L. DeFranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn deficient B lymphocytes. Curr. Biol. 8:545.
15. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-I are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497.
16. Buhl, A., and J. Cambier. 1999, Phosphorylation of CD19 Y484 and V515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162:4438.
17. Tuveson, D. A., R. H. Carter, S. P. Solthoff, and D. T. Fearon. 1993. CD19 of B cell as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986.
18. Fruman, D. A., S. B. Snapper, C. M. Yballe, L. Davidson, J. Y. Yu, F. W. Alt, and L. C. Cantley. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283:393.
19. Suzuki, A., J. L. de la Pompa, V. Stambolic, A. J. Elia, S. T. I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, W. Khoo, M. Fukumoto, and T. W. Mak. 1998. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1169.
20. Leevers, S. J., B. Vanhaesebroeck, and M. D. Waterfield. 1999. Signalling through phosphoinositide 3-kinase: the lipids take center stage. Curr. Opin. Cell Biol. 11:219.
21. Li, H.-L., W. W. Davis, E. L. Whiteman, M. J. Birnbaum, and E. Pure. 1999. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:6890.
22. Astoul, E., S. Watton, and D. Cantrell. 1999. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 145:1511.
23. Bellacosa, A., T. Franke, E. Gonzalez-Portal, K. Datta, T. Taguchi, J. Gardner, J. Cheng, J. Testa, and P. Tsichlis. 1993. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications Oncogene 8:745.
24. Staal, S. P., and J. W. Hartley. 1988. Thymic lymphoma induction by the AKTS murine retrovirus. J. Exp. Med. 167:1259.
25. Coffer, P. J., and J. R. Woodgett. 1991. Molecular-cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein-kinase-C families. Eur. J. Biochem. 201:475.
26. Jones, P. F., T. Jakubowicz, and B. A. Hemmings. 1991. Molecular cloning of a second form of RAC protein kinase. Cell Regul. 2:1001.
27. Jones, P. F., T. Jakubowicz, F. J. Pitossi, F. Maurer, and B. A. Hemmings. 1991. Molecular cloning and identification of a serine threonine protein-kinase of the 2nd-messenger subfamily. Proc. Natl. Acad. Sci. USA 88:4171.
28. Konishi, H., S. Kuroda, M. Tanaka, H. Matsuzaki, Y. Ono, K. Kameyama, T. Haga, and U. Kikkawa. 1995. Molecular-cloning and characterization of a new member of the RAC protein-kinase family: association of the pleckstrin homology domain of 3 types of RAC protein-kinase with protein-kinase-C subspecies and βγ-subunits of G-proteins. Biochem. Biophys. Res. Commun. 216:526.
29. Brodbeck, D., P. Cron, and B. A. Hemmings. 1999. A human protein kinase 87 with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J. Biol. Chem. 274:9133.
30. Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:262.
31. Alessi, D., and P. Cohen. 1998. Mechanisms of action and function of protein kinase B. Curr. Opin. Genet. Dev. 8:55.
32. Aoki, M., O. Batista, A. Bellacosa, P. Tsichlis, and P. K. Vogt. 1998. The Akt kinase: molecular determinants of oncogenicity. Proc. Natl. Acad. Sci. USA 95: 14950.
33. Cantley, L. C., and B. G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96:4240.
34. Di Cristofano, A., B. Pesce, C. Cordon-Cardo, and P. P. Pandolfi. 1998. PTEN is essential for embryonic development and tumor suppression. Nat. Genet. 19:348.
35. Podsypanina, K., L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher, and R. Parsons. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96:1563.
36. Morimoto, A. M., A. E. Berson, G. H. Fujii, D. H.-F. Teng, S. V. Tavtigian, R. Bookstein, P. A. Steck, and J. B. Bolen. 1999. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene 18:1261.
37. Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. A. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, et al. 1997. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:356.
38. Aman, M., T. Lamkin, H. Okada, K. Kurosaki, and K. Ravichandran. 1998. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 273:33922.
39. Gold, M., M. Scheid, L. Santos, M. Dang-Lawson, R. Roth, L. Matsuuchi, V. Duronio, and D. Krebs. 1999. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J. Immunol. 163:1894.
40. Li, J., L. Simpson, M. Takahashi, C. Miliaresis, M. P. Myers, N. Tonks, and R. Parsons. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58:5667.
41. Coffman, R. L., and M. Cohn. 1977. The class of surface immunoglobulin on virgin and memory B lymphocytes. J. Immunol. 118:1806.
42. Nadler, L., K. Anderson, G. Marti, M. Bates, E. Park, J. Daley, and S. Schlossman. 1983. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen activated, and malignant B lymphocytes. J. Immunol. 131: 244.
43. Sato, S., N. Ono, D. Steeber, D. Pisetsky, and T. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol. 156:4371.
44. Krop, I., A. Shaffer, and D. Fearon. 1996. The signaling activity of mutine CD19 is regulated during B cell development. J. Immunol. 157:48.
45. Craxton, A., A. Jiang, T. Kurosaki, and E. A. Clark. 1999. Syk and Burton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J. Biol. Chem. 274:30644.
46. Tooze, R., G. Doody, and D. Fearon. 1997. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59.
47. Fujimoto, M., J. Poie, P. Jansen, S. Sato, and T. Tedder. 1999. CD19 expression regulates tyrosine phosphorylation of Src-family protein tyrosine kinases following B cell receptor ligation. J. Immunol. 162:7088.
48. Zha, J., J. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619.
49. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544.
50. Kulik, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595.